[Clinical target volume delineation for radiotherapy of the esophagus]

Cancer Radiother. 2013 Oct;17(5-6):453-60. doi: 10.1016/j.canrad.2013.07.145. Epub 2013 Sep 4.
[Article in French]

Abstract

The dense lymphatic network of the esophagus facilitates tumour spreading along the cephalo-caudal axis and to locoregional lymph nodes. A better understanding of microscopic invasion by tumour cells, based on histological analysis of surgical specimens and analysis of recurrence sites, has justified a reduction in radiotherapy target volumes. The delineation of the clinical target volume (CTV) depends on tumour characteristics (site, histology) and on its spread as assessed on endoscopic ultrasonography and ((18)F)-fluorodeoxyglucose positron-emission tomography (FDG-PET). We propose that positive and negative predictive values for FDG-PET should be used to adapt the CTV according to the risk of nodal involvement.

Keywords: Cancer de l’œsophage; Clinical target volume; Conformal radiotherapy; Esophageal cancer; FDG-PET; Negative predictive value; Positive predictive value; Radiothérapie conformationnelle; TEP au FDG; Valeur prédictive négative; Valeur prédictive positive; Volume cible anatomoclinique.

MeSH terms

  • Endosonography
  • Esophageal Neoplasms / pathology*
  • Esophageal Neoplasms / radiotherapy*
  • Fluorodeoxyglucose F18
  • Humans
  • Lymph Nodes / radiation effects
  • Lymphatic Metastasis / diagnostic imaging
  • Positron-Emission Tomography
  • Predictive Value of Tests
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18